Bal Pharma has informed that a meeting of the board of directors of the company will be held on August 10, 2012, to take record and approve the un-audited financial results of the company for the quarter ended June 30, 2012 and the audited financial results of the company the financial year ended March 31, 2012.
Further, the board will propose issue and allotment of warrants on preferential basis to the promoters and to strategic investors, subject to the member’s approval, to approve the audited accounts of the company for the F.Y. ended March 31, 2012 along with the notice for AGM, directors report and corporate governance report and to decide on the book closure date and AGM date.
The above information is a part of company's filings submitted to BSE.
